Lunenfeld post-doctoral researcher and recent TD Bank Fellowship winner Dr. Nicole St-Denis is taking a systems biology approach to uncover the phosphatases involved in mitosis.
New Funding for Lunenfeld Scientists
Three Lunenfeld investigators will receive $22 million from an Ontario Ministry of Research and Innovation program that promotes internationally significant research in genomics.
Dr. Tony Pawson named ‘nation builder of the decade’
Dr. Tony Pawson, Distinguished Investigator at the Samuel Lunenfeld Research Institute, was named a ‘nation builder of the decade’ by The Globe and Mail.
Stem Cell Technology named ‘method of the year’
The 2009 stem cell breakthrough by the Lunenfeld’s Dr. Andras Nagy has been included among innovative discoveries celebrated by the prestigious journal Nature Methods.
The Lunenfeld: 2009 Research Breakthroughs
Over the past year The Samuel Lunenfeld Research Institute has made numerous breakthroughs. Throughout the remaining days of 2009 we will recap the amazing accomplishments coming out of The Lunenfeld.
Discovery Advances Cancer Research
Dr. Tony Pawson, Senior Investigator at the Samuel Lunenfeld Research Institute, and Dr. Rune Linding, of the UK's Institute of Cancer Research, have discovered a technique that allows scientists to monitor communication between cells for the first time and could revolutionize the way laboratory medical experiments are conducted.
Lunenfeld Scientists are Changing the World, says Toronto Life
A breast cancer technology tool and stress-busting glasses for nightshift workers, both developed by Lunenfeld investigators, are among Toronto Life’s “25 Ideas That Are Changing the World.”
Genetic Discoveries Advance Understanding of IBD
Genetic research conducted by Mount Sinai’s Dr. Mark Silverberg and colleagues around the world is helping to unravel the causes of Inflammatory Bowel Diseases, inspiring hope for better diagnostic and therapeutic tools.
Dr. Bernard Zinman Wins Award
November is Diabetes Awareness Month and we highlight the award-winning contributions to diabetes clinical care and research of Dr. Bernard Zinman.
Mount Sinai researchers discover the first-ever link between intelligence and curiosity
Scientists from the Samuel Lunenfeld Research Institute of Mount Sinai Hospital have discovered a molecular link between intelligence and curiosity, which may lead to the development of drugs to improve learning.
Genetic Cause of preeclampsia found
Clinician-scientist Dr. John Kingdom has discovered ways to manipulate a gene to potentially decrease the risk of preeclampsia, which affects up to 10,000 Canadian women every year.
Genetic “Road Map” to Liver Disease Discovered
A discovery by Mount Sinai’s Dr. Katherine Siminovitch could point the way to personalized treatment for people with a devastating liver disease.
Canadian Research Breakthrough Holds Promise for Development of Effective Cancer Therapies - Scientists identify new target for cancer cure
September 2, 2009
Researchers Dr. Marc Therrien at the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal, and Dr. Frank Sicheri, at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital in Toronto, have discovered a new target that may be instrumental in the development of new, more effective cancer therapies.
Epilepsy gene discovered; could lead to new treatments
August 3, 2009
Dr. John Roder, Senior Investigator at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital, has developed a method to prevent epilepsy caused by a gene defect in mice – an achievement which may herald new therapies for people suffering from the condition.
Human cells evolved to reduce cancer risk
July 9, 2009
Researchers at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital have found that as animals moved up the evolutionary chain they progressively shed molecules that are linked to cancer development.
Canada Foundation for Innovation announces more than $29.8 million to support Mount Sinai Hospital research
June 19, 2009
On June 18, 2009, the Canada Foundation for Innovation (CFI) announced funding support of more than $29.8 million (Cdn) towards several leading-edge research projects at Mount Sinai Hospital’s Samuel Lunenfeld Research Institute that will enable the most precise analyses of cancer and other diseases, and significantly accelerate efforts to develop new treatments.
Mount Sinai Hospital researcher gives new hope for patients with liver disease
May 15, 2009
Mount Sinai Hospital’s Dr. Katherine Siminovitch has discovered a new genetic pathway (a gene “road map”) that could provide personalized treatment options for patients with a devastating liver disease. The study offers great hope in treating other autoimmune diseases such as rheumatoid arthritis.
Dr. Andras Nagy makes SCIENTIFIC AMERICAN Top 10 Honor Roll
May 15, 2009
Mount Sinai Hospital’s Dr. Andras Nagy has been selected for the first annual SCIENTIFIC AMERICAN Top 10 Honor Roll. The only Canadian selected for the article, Dr. Nagy shares the honour with U.S. President Barack Obama, Bill Gates, Michael Bloomberg and other luminaries in the June 2009 issue of the magazine.
Dr. Daniel Drucker's career featured in Nature Reviews
April 30, 2009
Dr. Diamandis wins prestigious International Federation of Clinical Chemistry award
April 8, 2009
Dr. Eleftherios Diamandis, Lunenfeld Associate Member, has been named the first Canadian to win the prestigious international 2009 International Federation of Clinical Chemistry/Abbott Award for Significant Contributions to Molecular Diagnostics.
You are what you eat: Mount Sinai Hospital researcher discovers new test to assess overall diet quality
March 30, 2009
Mount Sinai Hospital’s Dr. Alexander Logan has discovered a new and easy way for physicians to check the overall quality of their patients’ diet, and help them improve their long-term health.
Mount Sinai Hospital researcher makes stem cell breakthrough
February 25, 2009
In a study to be released on March 1, 2009, Mount Sinai Hospital’s Dr. Andras Nagy discovered a new method of creating stem cells that could lead to possible cures for devastating diseases including spinal cord injury, macular degeneration, diabetes and Parkinson’s disease.
Ontario Government matches Kyoto Prize for Dr. Pawson's lab
February 18, 2009
Young scientists at Mount Sinai Hospital’s Samuel Lunenfeld Research Institute recently received an extra lift. The Ontario Minister of Research and Innovation, John Wilkinson, announced a generous matching grant of $500,000 in support of Dr. Tony Pawson’s Kyoto Prize on February 18, 2009, at a special lecture at the MaRS Discovery District.
Mount Sinai researcher discovers how genetic link causes preeclampsia in pregnant women
February 12, 2009
A new study led by a Mount Sinai Hospital clinician-scientist has found new ways to manipulate a gene that could potentially decrease a pregnant woman’s risk of preeclampsia - a severe type of high blood pressure in pregnancy that can cause serious medical problems for both the mother and baby.
Dr. Robert Casper's new invention improves health of night shift workers
February 2, 2009
People who work the ‘graveyard shift’ are thought to be at an increased risk of breast and colon cancer, heart disease, anxiety disorders and obesity because of repeated disruptions to their biological clock due to exposure to light at night. Lunenfeld senior investigator Dr. Robert Casper and doctoral candidate Shadab Rahman wanted to find out if these disruptions could be prevented.
New technology predicts breast cancer outcomes
February 1, 2009
Mount Sinai Hospital researchers have unveiled a new technology tool that analyzes breast cancer tumours to determine a patient’s best treatment options. The tool can predict with more than 80 per cent accuracy a patient’s chance of recovering from breast cancer.
New genetic discovery sheds light on ulcerative colitis
January 5, 2009
In a study published by Nature Genetics on January 4, 2009, an international team of geneticists and gastroenterologists led by Mount Sinai Hospital’s Dr. Mark Silverberg have discovered a new genetic link to ulcerative colitis, an inflammatory bowel disease that affects approximately 200,000 Canadians.